InSphero at the American College of Toxicology 2024
Join us at the American College of Toxicology 2024 Annual Meeting in Austin, Texas. This key event gathers professionals from the toxicology community to exchange insights, research, and innovations. We look forward to connecting with fellow attendees and engaging in valuable discussions.
Discover all our activities that will be taking place during the ACT Annual Meeting 2024 in Austin, Texas from Sunday, November 17 to Wednesday, November 20. See you there!
Meet our Team at the American College of Toxicology 2024
Paul Edgard Clémençon, MBA
Chief Business Officer
Paul Edgard Clémençon, MBA
Chief Business Officer
A seasoned commercial leader with 18+ years of experience in senior sales and marketing roles in small and large corporations. Paul holds a chemistry degree from the University of Applied Sciences of Northwestern Switzerland and an Executive MBA from the University of Zurich.
Prior to joining InSphero, Paul served as VP of Strategic Partnerships Europe at eMolecules Inc., a San Diego-based growth company providing solutions for drug discovery to big pharma, biotech, and academic institutions.
Bruno Filippi, PhD
Vice President, Liver Safety
Bruno Filippi, PhD
Vice President, Liver Safety
Bruno is an experienced and versatile biologist who worked at the crossroads between cell biology, advanced in vitro models, and biochemistry in various European academic and technical research institutions for more than 15 years. Bruno holds a PhD in cell biology from the University of Zürich and thrives to turn innovation into applications.
Arumugham (Ragoo) Raghunathan, PhD
Senior Director Business Development
Arumugham (Ragoo) Raghunathan, PhD
Senior Director Business Development
Arumugham (Ragoo) Raghunathan earned his Ph.D. in Animal Sciences from the University of Hyderabad, with research on DNA-binding proteins in the rat brain. He pursued postdoctoral work at Wesleyan and Yale, later co-inventing Whole Genome Amplification (WGA) technology at Molecular Staging Inc., a key innovation in Next-Generation Sequencing, now commercialized by Qiagen.
Ragoo transitioned smoothly from academia to industry, holding leadership roles in business development and technology at Sigma Aldrich, Horizon Discovery, and Metabolon Inc. He is currently Senior Director at InSphero, driving revenue growth across the Eastern U.S.
Maria Vittoria Colombo, PhD
Scientist / Product Coordinator
Maria Vittoria Colombo, PhD
Scientist / Product Coordinator
Maria Vittoria Colombo is a Scientist and Product Coordinator of Liver Safety at InSphero. In her role, she manages service projects and is responsible for the development and maintenance of the cross-species liver spheroids portfolio.
Maria Vittoria earned her PhD in Bioengineering from Politecnico di Milano, where her research focused on developing Microphysiological Systems to investigate the bone-tumor microenvironment. Her research involved partnership with EOC hospital and DBM Basel in Switzerland, as well as the German Cancer Research Center in Germany.
Our Booth at the American College of Toxicology 2024
Visit our booth #503 and discover our 3D InSight™ Liver Safety - Practical, Physiological & Cost-effective 3D In Vitro Solutions for DILI Assessment
Poster at the American College of Toxicology 2024
Species-Specific Liver Microtissues: A Set of Microphysiological Systems to Assess Translational Hepatotoxicity in Drug Development
Date: Monday, 18 November, 2024 | 5:00 - 6:30 PM
Poster number: P405
Maria Vittoria Colombo, PhD
Scientist / Product Coordinator
Maria Vittoria Colombo, PhD
Scientist / Product Coordinator
Maria Vittoria Colombo is a Scientist and Product Coordinator of Liver Safety at InSphero. In her role, she manages service projects and is responsible for the development and maintenance of the cross-species liver spheroids portfolio.
Maria Vittoria earned her PhD in Bioengineering from Politecnico di Milano, where her research focused on developing Microphysiological Systems to investigate the bone-tumor microenvironment. Her research involved partnership with EOC hospital and DBM Basel in Switzerland, as well as the German Cancer Research Center in Germany.
Exhibitor-Hosted Session at the American College of Toxicology 2024
In Vitro Hepatotoxicity Assessment with the 3D InSight™ Liver Microtissue Platform
Date: Tuesday, 19 November, 2024 | 12:00 - 12:55 PM
Location: Level 2, Room 204
Presentation of the 3D InSight™ Liver microtissue platform, a versatile, scalable, and industry-compatible in vitro system, and of its uses for predictive, investigative, and translational hepatotoxicity assessment applications.
Bruno Filippi, PhD
Vice President, Liver Safety
Bruno Filippi, PhD
Vice President, Liver Safety
Bruno is an experienced and versatile biologist who worked at the crossroads between cell biology, advanced in vitro models, and biochemistry in various European academic and technical research institutions for more than 15 years. Bruno holds a PhD in cell biology from the University of Zürich and thrives to turn innovation into applications.
